Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Jul;76(897):390–394. doi: 10.1136/pmj.76.897.390

Pulmonary arteriovenous malformations: a clinical review

M Iqbal 1, L Rossoff 1, H Steinberg 1, K Marzouk 1, D Siegel 1
PMCID: PMC1741661  PMID: 10878194

Abstract

Pulmonary arteriovenous malformations (PAVMs) are a rare clinical entity. Most of them are associated with hereditary haemorrhagic telangiectasia. The usual clinical presentation is exertional dyspnoea and hypoxaemia. The initial test of choice for screening is the 100% oxygen method. A pulmonary angiogram is needed to define the anatomy and guide transcatheter embolisation (TCE). TCE has been shown to be effective and safe with a very low recanalisation rate and has largely replaced surgery for PAVMs. Computed tomography of the chest can be used for the follow up of asymptomatic PAVMs and TCE.


Keywords: arteriovenous malformation; hypoxaemia; shunt study; embolisation

Full Text

The Full Text of this article is available as a PDF (159.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barzilai B., Waggoner A. D., Spessert C., Picus D., Goodenberger D. Two-dimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformations. Am J Cardiol. 1991 Dec 1;68(15):1507–1510. doi: 10.1016/0002-9149(91)90287-u. [DOI] [PubMed] [Google Scholar]
  2. Chiang S. T. Anomogram for venous shunt (Qs-Qt) calculation. Thorax. 1968 Sep;23(5):563–565. doi: 10.1136/thx.23.5.563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coley S. C., Jackson J. E. Pulmonary arteriovenous malformations. Clin Radiol. 1998 Jun;53(6):396–404. doi: 10.1016/s0009-9260(98)80267-5. [DOI] [PubMed] [Google Scholar]
  4. Ference B. A., Shannon T. M., White R. I., Jr, Zawin M., Burdge C. M. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest. 1994 Nov;106(5):1387–1390. doi: 10.1378/chest.106.5.1387. [DOI] [PubMed] [Google Scholar]
  5. Gossage J. R., Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. 1998 Aug;158(2):643–661. doi: 10.1164/ajrccm.158.2.9711041. [DOI] [PubMed] [Google Scholar]
  6. Guttmacher A. E., Marchuk D. A., White R. I., Jr Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995 Oct 5;333(14):918–924. doi: 10.1056/NEJM199510053331407. [DOI] [PubMed] [Google Scholar]
  7. Haitjema T., Disch F., Overtoom T. T., Westermann C. J., Lammers J. W. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med. 1995 Nov;99(5):519–524. doi: 10.1016/s0002-9343(99)80229-0. [DOI] [PubMed] [Google Scholar]
  8. Haitjema T., Westermann C. J., Overtoom T. T., Timmer R., Disch F., Mauser H., Lammers J. W. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med. 1996 Apr 8;156(7):714–719. [PubMed] [Google Scholar]
  9. Johnson D. W., Berg J. N., Baldwin M. A., Gallione C. J., Marondel I., Yoon S. J., Stenzel T. T., Speer M., Pericak-Vance M. A., Diamond A. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996 Jun;13(2):189–195. doi: 10.1038/ng0696-189. [DOI] [PubMed] [Google Scholar]
  10. Lee D. W., White R. I., Jr, Egglin T. K., Pollak J. S., Fayad P. B., Wirth J. A., Rosenblatt M. M., Dickey K. W., Burdge C. M. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg. 1997 Oct;64(4):930–940. doi: 10.1016/s0003-4975(97)00815-1. [DOI] [PubMed] [Google Scholar]
  11. Marshall J. K., Hunt R. H. Hormonal therapy for bleeding gastrointestinal mucosal vascular abnormalities: a promising alternative. Eur J Gastroenterol Hepatol. 1997 May;9(5):521–525. doi: 10.1097/00042737-199705000-00020. [DOI] [PubMed] [Google Scholar]
  12. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994 Dec;8(4):345–351. doi: 10.1038/ng1294-345. [DOI] [PubMed] [Google Scholar]
  13. Remy J., Remy-Jardin M., Giraud F., Wattinne L. Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology. 1994 Jun;191(3):657–664. doi: 10.1148/radiology.191.3.8184042. [DOI] [PubMed] [Google Scholar]
  14. Sagara K., Miyazono N., Inoue H., Ueno K., Nishida H., Nakajo M. Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. AJR Am J Roentgenol. 1998 Mar;170(3):727–730. doi: 10.2214/ajr.170.3.9490963. [DOI] [PubMed] [Google Scholar]
  15. Shovlin C. L., Hughes J. M., Tuddenham E. G., Temperley I., Perembelon Y. F., Scott J., Seidman C. E., Seidman J. G. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994 Feb;6(2):205–209. doi: 10.1038/ng0294-205. [DOI] [PubMed] [Google Scholar]
  16. Shovlin C. L., Winstock A. R., Peters A. M., Jackson J. E., Hughes J. M. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM. 1995 Dec;88(12):879–887. [PubMed] [Google Scholar]
  17. Silverman J. M., Julien P. J., Herfkens R. J., Pelc N. J. Magnetic resonance imaging evaluation of pulmonary vascular malformations. Chest. 1994 Nov;106(5):1333–1338. doi: 10.1378/chest.106.5.1333. [DOI] [PubMed] [Google Scholar]
  18. Terry P. B., White R. I., Jr, Barth K. H., Kaufman S. L., Mitchell S. E. Pulmonary arteriovenous malformations. Physiologic observations and results of therapeutic balloon embolization. N Engl J Med. 1983 May 19;308(20):1197–1200. doi: 10.1056/NEJM198305193082005. [DOI] [PubMed] [Google Scholar]
  19. Wagner P. D., Laravuso R. B., Uhl R. R., West J. B. Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2. J Clin Invest. 1974 Jul;54(1):54–68. doi: 10.1172/JCI107750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. White R. I., Jr, Pollak J. S., Wirth J. A. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol. 1996 Nov-Dec;7(6):787–804. doi: 10.1016/s1051-0443(96)70851-5. [DOI] [PubMed] [Google Scholar]
  21. Whyte M. K., Peters A. M., Hughes J. M., Henderson B. L., Bellingan G. J., Jackson J. E., Chilvers E. R. Quantification of right to left shunt at rest and during exercise in patients with pulmonary arteriovenous malformations. Thorax. 1992 Oct;47(10):790–796. doi: 10.1136/thx.47.10.790. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES